OrganaBio buys operating assets of Excellos, establishes a coast-to-coast cell therapy contract testing, development and manufacturing organization: Miami Saturday, May 16, 2026, ...
The US Food and Drug Administration (FDA) has released a final guidance document with immediate effect advising sponsors on ...
It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...
Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...
Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort Study Healthy volunteers were recruited and underwent ...
OrganaBio, LLC ("OrganaBio"), a manufacturer of GMP cells and blood products and provider of cell isolation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results